Reports Q3 revenue $2.19M, consensus $2.15M. “We exceeded $2.0 million in quarterly revenue which marks an important milestone as we continue scaling our business and building awareness of the benefits our tankless NO system delivers in real-world settings,” said Steve Lisi, Chief Executive Officer of Beyond Air (XAIR). “Our commercial performance reflects steady momentum, with 21% sequential quarterly growth and a 105% increase over the same quarter last year. We will continue to grow our business with LungFit PH as we prepare for the FDA clearance of our second-generation LungFit PH system, which we expect to receive before the end of calendar 2026, subject to regulatory review. We believe the significant enhancements, including reduced weight and footprint, simplified operation, longer service interval, and full compatibility with both air and ground transport, will dramatically accelerate market share gains and position Beyond Air as a global leader in hospital-based NO delivery.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XAIR:
- XAIR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Beyond Air Stockholders Approve Directors and Equity Plan
- Beyond Air files to sell 7.86M shares of common stock for holders
- XTL Biopharmaceuticals provides update on recent developments
- Beyond Air Announces $5 Million Private Placement Financing
